With CBD growing in popularity all across the world, the spread of misinformation has been rampant.
This week, we’ll take a look at some of the most commonly believed CBD myths and finally get down to the truth of the matter. Also, did you know THC can help the older generations with memory and ability to focus by regenerating brain cells? Plus, learn how CBD can help people struggling with opioid addiction. All that and more in this week’s Medical Cannabis Weekly Newsletter and Review.
CBD, short for Cannabidiol, is an active compound inside cannabis and hemp. Unlike THC, CBD offers many therapeutic benefits without the psychoactive effects. With all the talk surrounding this cannabinoid lately, it can be difficult to separate the real from the fake. Let’s take a look at some of the most common myths and dispel them once and for all.
It’s pretty common knowledge that regular cannabis use during teen years can cause a lack of focus and short-term memory loss. While the effects are typically not permanent, it’s still not ideal. However, when it comes to the older generations, the exact opposite is true. That’s right, cannabis can help older people improve their focus, memory, and cognition.
A new clinical trial revealed that CBD can help tremendously with anxiety and depression related to opioid addiction – which has reached epidemic levels in the United States. With an average of 130 overdose deaths every single day, President Trump declared it a national emergency and launched an initiative to battle the widespread crisis. Research indicates that cannabis an overall positive effect on opioid addiction.
Although it’s been years since Israel legalized medical cannabis for certain qualifying patients, the sad reality is that this haven of cannabis research has always been littered with red tape, inconsistent regulations, and frequent price increases. However, this is finally about to change fore the better. According to Deputy Health Minister Ya’acov Litzman, “We are attentive to criticism and to improving in order to ease the suffering of patients and will continue to promote further activities on the matter,” ‘
OTHER TRENDING NEWS
Following a public meeting on May 31st regarding CBD regulations, many were expecting guidance by now but they claim the FDA continues to drag their feet. Lawmakers are now turning up the heat in an attempt to get the FDA to draft some official regulations regarding the sale of CBD-infused food, supplements and cosmetics.
According to Mike Harlington from The Cannabis Trades Association, “The CMC issued a report a few days ago, and in true CMC form (and UPA and everything else connected with Liebling and Moore) it’s fatally flawed. Anyone who has ever been involved with these people know that they have always gotten entangled with CBD products and medicinal cannabis with an aim to control them.”